U.S. markets closed

China Natural Resources, Inc. (CHNR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3000+0.0600 (+4.84%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.2400
Open1.2800
Bid1.2500 x 1000
Ask1.3800 x 1100
Day's Range1.2500 - 1.3000
52 Week Range0.7500 - 6.0400
Volume46,298
Avg. Volume657,888
Market Cap49.333M
Beta (5Y Monthly)1.09
PE Ratio (TTM)9.35
EPS (TTM)0.1390
Earnings DateJun 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • China Natural Resources Reports Full Year 2020 Results
    PR Newswire

    China Natural Resources Reports Full Year 2020 Results

    CHINA NATURAL RESOURCES, INC. (NASDAQ: CHNR) (the "Company") today announced its results of operations for the year ended December 31, 2020. For the convenience of the reader, amounts in Chinese Yuan ("CNY") have been translated into United States dollars ("US$") at the rate of US$1.00 = CNY6.5306 as quoted by www.ofx.com on December 31, 2020.

  • China Natural Resources Appoints 20-year Pharmaceutical Executive Dr. Peng Wenlie as Vice President
    PR Newswire

    China Natural Resources Appoints 20-year Pharmaceutical Executive Dr. Peng Wenlie as Vice President

    China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") announced today the appointment of pharmaceutical industry executive Peng Wenlie as Vice President, effective March 22, 2021. Dr. Peng, who brings more than 20 years of experience working in the industry, will report directly to the Company's Chairman, Mr. Wong Wah On Edward. He will be responsible for evaluating the Company's investment opportunities in the healthcare, biomedicine, and related markets.

  • China Natural Resources, Inc. Announces The Closing Of $7.3 Million Registered Direct Offering
    PR Newswire

    China Natural Resources, Inc. Announces The Closing Of $7.3 Million Registered Direct Offering

    CHINA NATURAL RESOURCES, INC. (NASDAQ: CHNR) (the "Company") today announced that it closed the registered direct offering of approximately $7.3 million of common shares at a price of $1.85 per share on January 22, 2021, as previously announced on January 20, 2021. The Company issued a total of 3,960,000 common shares to the institutional investors participating in the offering. In a concurrent private placement, the Company also issued warrants ("Warrants") to the investors, initially exercisable for the purchase of up to 1,584,000 common shares at an exercise price of $2.35 per share, which Warrants have a term of 36 months from the date of issuance. The net proceeds from this offering will be used for general corporate purposes.